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Abstract
Background: As eHealth interventions prove both efficacious and practical, and as they arguably overcome certain
barriers encountered by traditional face-to-face treatment for chronic pain, their number has increased dramatically
in recent times. However, there is a dearth of research that focuses on evaluating and comparing the different types of
technology-assisted interventions. This is a protocol for a systematic review that aims to evaluate the eHealth
modalities in the context of psychological and non-psychological (other than non-drug) interventions for chronic pain.
Methods/design: We will search the Cochrane Central Register of Controlled Trials (CENTRAL: The Cochrane Library),
MEDLINE, Embase and PsycINFO. Randomised controlled trials (RCTs) with more than 20 participants per trial arm that
have evaluated non-drug psychological or non-psychological interventions delivered via an eHealth modality and have
pain as an outcome measure will be included. Two review authors will independently extract data and assess the study
suitability in accordance with the Cochrane Collaboration Risk of Bias Tool. Studies will be included if they measure at
least one outcome variable in accordance with the IMMPACT guidelines (i.e. pain severity, pain interference, physical
functioning, symptoms, emotional functioning, global improvement and disposition). Secondary outcomes will be
measures of depression and health-related quality of life (HRQoL). A network meta-analysis will be conducted based on
direct comparisons to generate indirect comparisons of modalities across treatment trials, which will return rankings for
the eHealth modalities in terms of their effectiveness.
Discussion: Most trials that use an eHealth intervention to manage chronic pain typically use one modality. As a result,
little evidence exists to support which modality type is the most effective. The current review will address this gap in
the literature and compare the different eHealth modalities used for technology-assisted interventions for chronic pain.
With the growing reliance and use of technology as a medium for delivering treatment for chronic conditions more
generally, it is imperative that research identify the most efficacious eHealth modalities and systematically identify the
most important features of such treatment types, so they may be replicated and used for research and in the provision
of care.
Trial registration: PROSPERO, CRD42016035595
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eHealth refers to the deployment of information com-
munication technologies in the healthcare and health re-
search sectors [1, 2]. Technological advancements and
the now ubiquitous nature of technology in daily life
offer unprecedented options for delivering health-related
interventions. In particular, eHealth interventions for
chronic long-term health conditions are becoming in-
creasingly popular, as they offer solutions to some of the
typical barriers people experience, including, for ex-
ample, travel and mobility issues, treatment availability,
lack of clinicians with adequate expertise, and financial
barriers [3–5]. Indeed, as the value of technology in
health research is realised and as the exponential growth
and sophistication of eHealth modalities continues, re-
searchers are experimenting with an increasing variety of
these modalities in an effort to deliver, assist and support
treatment interventions for chronic conditions [3, 6–9].
Examples of eHealth interventions in health research in-
clude online interventions, telephone support [6, 10–12],
interactive voice response (IVR) [8], virtual reality [7] and
mobile phone applications [9]. Importantly, research has
found that these technology-assisted interventions for
chronic health conditions are efficacious, and promising
results have emerged for eHealth research where chronic
pain is the outcome of interest.
eHealth and chronic pain
Chronic pain (CP) refers to an unpleasant sensory and
emotional experience that relates to actual or potential tis-
sue damage (or described by a person in terms of such
damage) that persists for more than 3 months [13]. CP is a
highly prevalent condition and one of the most common
causes of long-term disability [14]. Due to these factors,
and as the treatment of chronic conditions more generally
turns toward self-management [15], there is increasing
support for eHealth interventions for chronic pain, as evi-
denced by their increasing numbers in the research litera-
ture. The most common eHealth interventions for chronic
pain are Internet-based self-management programmes that
typically provide psychotherapeutic content [3, 16].
Recently, a systematic review with a meta-analysis was
conducted to evaluate the effectiveness of Internet-
delivered psychological therapies for chronic pain. Eccles-
ton et al. found that participants with headache conditions
experienced reduced pain, and they also identified a mod-
erate effect for participant disability post-treatment [16]. In
participants with non-headache conditions, the researchers
found that psychological treatments improved pain symp-
toms post-treatment, disability at post-treatment and at
follow-up. In addition, moderate effects for depression and
anxiety post-treatment were found. However, in their re-
view, Eccleston et al. note that the majority of included
studies were online cognitive behavioural therapy (CBT),
and as such, the results cannot be extrapolated to other
treatment types or modalities [16].
Heapy et al. [3] have highlighted that technology lit-
erature in other health-related research areas is more ad-
vanced than it is in the research domain of chronic pain.
For example, several reviews with meta-analyses exist
examining the effects of different technology-assisted in-
terventions for depression and anxiety (e.g. Newman et
al. [17], Richards et al. [18]). Moreover, as Heapy et al.
[3] argue that despite the increasing use of different
eHealth modalities deployed in chronic pain interven-
tions specifically, most studies and reviews focus on one
modality (e.g. Eccleston et al. [16]). As a result, this type
of research negates the important contribution of com-
paring the relative strengths and weaknesses of different
modalities. In an effort to address these issues and ex-
tend the research on technology-assisted treatments for
chronic pain, Heapy et al. conducted a systematic review
of the different types of technology-assisted interventions;
specifically, they examined the efficacy of telephone, inter-
active voice response (IVR) and Internet-assisted treat-
ments for chronic pain. From their review, Heapy et al.
concluded that telephone, IVR and Internet-based inter-
ventions were effective for the treatment of chronic pain.
While Heapy et al. were the first to explore and sum-
marise the scope and efficacy of eHealth treatment mo-
dalities for chronic pain, there are limitations in their
work. For example, Heapy et al. restricted their review
to three forms of technology. Furthermore, their findings
were based on a systematic review that included a var-
iety of study types, not just randomised controlled trials,
and although effect sizes were calculated, the review was
primarily descriptive and the effect sizes could only be
used for illustrative purposes, as opposed to being used
to quantitatively compare technologies. As a result, and
as Heapy et al. conclude, ‘current research has yet to find
that one of the technology-assisted interventions is su-
perior to the others’ [3]. In fact, Heapy et al. argue that
future research should directly compare different
technology-assisted modalities in an effort to identify the
most effective approach for the provision of chronic pain
self-management [3].
Why is it important to do this review?
Though there has been a rise in the number of
technology-assisted interventions for chronic pain, there
is a dearth of research to evaluate the efficacy and rela-
tive strengths and weaknesses of these modalities [3].
From the perspectives of research, healthcare provision
and patient well-being, it is extremely important to iden-
tify the most effective modality and, in turn, highlight its
most efficacious components, such as administrative
contact level, therapist contact level, use of automatic
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feedback and attrition rates, that would inform and im-
prove future eHealth interventions. Therefore, the aim of
the current research is to evaluate the efficacy of interven-
tions delivered via eHealth modalities for chronic pain
and build upon the research conducted by Eccleston et al.
and Heapy et al. [3, 16]. Specifically, the current review
will combine the robustness of the search strategy from
Eccleston’s Cochrane review with the research aims of
Heapy et al. The current review will further extend their
work by using quantitative analysis, namely a network
meta-analysis (NMA), to compare and rank the eHealth
modalities used for interventions in chronic pain. In the
context of a systematic review, an NMA is a statistical
technique that enables multiple treatments to be com-
pared using direct and indirect comparisons across trials
using a common comparator (see, Jansen et al. [19], Naci
et al. [20], for further discussion).
Objective
The objective of this review is to evaluate and compare
the effectiveness of eHealth modalities delivering psy-
chological and non-psychological (other than drug) in-
terventions for chronic pain.
Methods
Criteria for considering studies for this review
This systematic review and NMA will be conducted and
reported in accordance with the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines and the PRISMA Network Meta-Analysis exten-
sion statement (see Additional file 1) [21, 22]. The protocol
for this study was registered with the International
Prospective Register of Systematic Reviews (PROSPERO)
database (registration number: CRD42016035595). In ac-
cordance with the PRISMA checklist recommendations,
this review will use the PICO process for framing and
reporting the review criteria; as such, the participants, in-
terventions, comparisons, outcome(s) and study design of
the included studies will be reported.
Description of details used from Eccleston et al. [16] and
Heapy et al. [3]
Many of the fundamental decisions taken in planning
this review were influenced by two recent systematic re-
views in the area of eHealth and chronic pain, namely
Eccleston’s Cochrane review [16] and Heapy et al. [3].
As a Cochrane review, typically considered the gold
standard for systematic reviews and in the area of
eHealth and chronic pain, the review of Eccleston et al.
was an ideal foundation to inform the current research.
Specifically, the number of databases and the type of da-
tabases chosen for this review were identical to those
used by Eccleston et al. The current search strategy is
also based on Eccleston’s review with the majority of the
same search terms used. The review of Eccleston et al.
also informed our inclusion and exclusion criteria (for
example, only RCTs from peer-reviewed journals will be
included) and the additional variables (for example, age
and source) that will be extracted from the included
studies. In turn, the review of Heapy et al. [3], which fo-
cused on different technological modalities used in
chronic pain research, informed the search strategy by
providing an outline of the various eHealth modalities to
be included.
Types of studies
This review will include RCTs that compare eHealth in-
terventions for managing chronic pain with treatment-
as-usual, enhanced control, waiting list control and/or
an active eHealth intervention.
Types of participants
Participants must be over 18 years old and living with
non-cancer-related chronic pain, which is defined as ‘an
unpleasant sensory and emotional experience associated
with actual or potential tissue damage, or described by
the patient in terms of such damage’ that persists for a
period in excess of 3 months [13]. As a point of note,
similar to previous literature (e.g. Eccleston et al. [16]),
cancer-related pain has not been included in this review.
Cancer-related pain, while it may become chronic, is
generally differentiated from other forms of chronic pain
(e.g. neuropathic and musculoskeletal) in the research
literature, as it follows a different disease progression,
with different treatment and management programmes.
Types of interventions
Included studies must deliver the experimental interven-
tion via a technological modality (such as Internet, tele-
phone, interactive voice response or mobile application).
Studies must report the effects of the intervention on
some form of pain-related outcome to be included. The
review will include studies with psychological and non-
psychological interventions (for example, educational
programmes, diaries and self-management programmes).
Studies that evaluate drug treatments will not be in-
cluded. Psychological interventions are those that expli-
citly deliver a psychological component as a treatment
(for example, psychotherapy for pain management).
Types of outcome measures
Primary outcomes
Included studies must have pain as an outcome, either
as a primary outcome or within a cluster measurement
of physical functioning or health-related quality of life.
In accordance with the recommendations outlined by
IMMPACT [23], which describes the core outcome mea-
sures for chronic pain, studies will be included if they
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provide measures for any of the following variables: pain
severity, pain interference, physical functioning, symp-
toms, emotional functioning, global improvement and
disposition.
Secondary outcomes
Secondary outcomes will include administered or self-
reported scales of depression and measures of health-
related quality of life.
Search method for identification of studies
Studies must be full-text journal articles in English, pub-
lished in peer-reviewed journals and available through a
database access or contact with the study authors. Data-
bases will be searched from inception.
Electronic searches
The following databases will be searched: CENTRAL
(Cochrane Library), MEDLINE, Embase and PsycINFO.
Search strategies for each database will be the same;
however, suitable changes will be made to accommodate
the different interfaces. The search strategy is detailed in
Additional file 2: Table S1.
Searching other resources
The reference lists of relevant systematic reviews and of
included studies will be searched in order to identify add-
itional studies that may be relevant. The metaRegister of
controlled trials (mRCT) (http://www.isrctn.com/page/
mrct), clinicaltrials.gov (www.clinicaltrials.gov) and the
WHO International Clinical Trials Registry Platform
(ICTRP) (apps.who.int/trialsearch/) will also be
screened. This review will only include studies that
have been published in peer-reviewed journals; as
such, unpublished papers, dissertations and ongoing
studies will not be incorporated.
Data collection and analysis
Selection of studies
Studies that are identified by our search strategy will be
managed using Endnote X7 [24]. Members of the re-
search team will initially screen titles and abstracts to
search for any duplicate studies. Members of the re-
search team will then screen for any studies that are not
relevant and will exclude them into a global exclusion
folder. Two reviewers will screen 10% of the papers in
duplicate to ensure consistency. Where authors disagree
on the relevance of a paper, a conservative approach will
be taken and the paper will be included in the detailed
screening. At this stage, any remaining non-English lan-
guage papers will be excluded. Two review authors (SH
and KF) will independently screen the remaining titles,
abstracts and, where necessary, full papers for inclusion
in agreement with the exclusion criteria. Papers that do
not satisfy the criteria will be systematically and sequen-
tially excluded via the exclusion categories; the reason
for exclusion will be recorded. Any disagreements be-
tween the reviewers will be resolved by discussion and
where a decision cannot be reached, a third reviewer
(BS) will mediate. A flow chart will be created to graph-
ically depict the inclusion and exclusion of studies from
the initial search to those that satisfy all criteria and will
be included in the review.
Data extraction and management
Two review authors will independently extract data into
a pre-prepared data extraction excel sheet, which will be
piloted on a sample of three studies and amended if re-
quired before data extraction proper. Authors will be
contacted to retrieve any missing data.
 A brief note of the study design and the assessment
time points
 Participants: number of participants at pre- and
post-intervention, sex, mean age, source
(recruitment), diagnosis and mean years of pain
 Interventions and a brief description of the modules
included
 The primary measure used to record for each
outcome
 Means and standard deviations of each outcome
measure will be extracted at post-intervention for all
treatment groups
The reviewers will also extract information on the
level of contact that the participant has with therapists/
researchers.
Classification of arms
The arms of each study will be classified as either psy-
chological or non-psychological (for example, CBT as
psychological and a pain diary as non-psychological).
This classification will be completed separately by re-
searchers SH and KF and then discussed to resolve any
differences in conjunction with BS. Each arm will then
be classified as a modality; this will refer to the main
eHealth delivery used within the study (for example, an
intervention delivered primarily online would be classed
as an Internet modality). There is space available for a
psychological and non-psychological arm within each
modality (for example, psychological Internet and non-
psychological Internet). This is an unusual network
where interventions typically compared will be pooled
together if delivered by the same modality (for example,
CBT and acceptance and commitment therapy). The
arms will then be used to create a network diagram in
order to graphically depict the evidence.
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Geometry of the network
The network diagram will graphically depict the avail-
able evidence and give an indication of the volume of
evidence behind each comparison. It also gives a visual
representation of the possible comparisons where any
two modalities can be compared as long as both are
connected to the network.
Assessment of risk of bias in included studies
In line with Eccleston et al. [16], this review will assess
the risk of bias using the Cochrane Collaboration Risk of
Bias tool where they are classified as being of low, high
or an unclear risk of bias based on the following six
domains:
Random sequence generation bias: This examines how
the studies generated a random sequence. If studies
state that they used an online randomiser, coin tossing,
random number table etc., then they are considered to
be of low risk, studies that described a non-random
component are considered to be high risk.
Allocation concealment: This domain determines
whether allocation was adequately concealed from
participants and investigators. Studies that used central
allocation, sequentially numbered opaque sealed
envelopes etc. are of low risk, while those that used an
open random allocation schedule, date of birth,
rotation etc. are considered to be of high risk.
Blinding of participants, personnel and outcome
assessors: This domain covers both performance and
detection bias. Studies where the reviewer felt the
outcome measure was not likely to be influenced by a
lack of blinding, blinding of key personnel etc. return a
low risk of bias. While studies where there was no
blinding, incomplete blinding or it is likely that
blinding could have been broken are all considered
to be at high risk.
Incomplete outcome data: Assessing whether attrition
or the reporting of attrition leads to bias. If studies
have no missing data, missing outcome data is balanced
across intervention groups, if they have been properly
imputed etc., then there is a low risk of bias; if there is
a reason to be related to the true outcome,
inappropriate application of imputation methods etc.,
then a high risk of bias is reported.
Selective reporting bias: If results for all relevant/pre-
stated outcomes were reported, then the study is at low
risk; if results are not reported or results are given for
outcomes that were not pre-specified, then the study is
at a high risk of bias. The tool suggests that most
studies will be of unclear risk due to insufficient
information.
Additional sources of bias: Assessed to determine
whether any problems with the study could cause
additional bias. If free of other sources, then it is considered
low risk; if there is at least one important risk of bias (e.g.
has an extreme baseline imbalance), it is at a high risk.
Eccleston’s review focused on psychological interven-
tions and, therefore, only examined whether outcome
assessors were blinded, as it was impossible to blind par-
ticipants/personnel to the intervention [16]. This study
will include non-psychological interventions; therefore,
the blinding of participants and personnel as well as out-
come assessors will be considered where necessary. It is
anticipated that all studies included in Eccleston’s
Cochrane review will satisfy the criteria for this study;
therefore, bias will not be reassessed for those studies.
However, reviewers will assess bias for three of their in-
cluded studies to ensure that our assessment of bias is
comparable. Bias of any additional studies will then be
assessed independently by two researchers (BS and SH).
Summary measures
This review will use Stata 13 and WinBUGS 1.4 for all
analyses [25, 26]. For continuous data, mean differences
between groups and 95% confidence intervals will be re-
ported. Where comparable outcomes are measured using
different tools, standardised mean differences (SMDs) will
be calculated and reported with their 95% confidence in-
tervals. If no standard deviations are reported, we will at-
tempt to calculate them from the available standard errors
or confidence intervals. Additional summary measures,
such as treatment rankings and the surface under the cu-
mulative ranking curve, will be reported.
Planned methods of analysis
The purpose of this review is to generate comparisons
between modalities with a view of determining which
modality more effectively delivers psychological and
non-psychological interventions for chronic pain. As
such, studies will be pooled across a variety of interven-
tions if the measured outcomes are comparable and the
data is available.
Exploratory analysis (pairwise meta-analyses) If com-
parable data is available, pairwise meta-analyses of each
modality will be run as an exploratory analysis in order
to explore the data. Given that significant heterogeneity
is expected, a random effects model will be used. The
meta-analyses will be conducted using Stata 13. Forrest
plots will also be created to graphically depict the indi-
vidual and pooled effect sizes.
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Network meta-analysis A pairwise meta-analysis is
used to combine several comparisons of the same two
interventions (e.g. A and B). The basis of NMA is the in-
clusion of a third intervention (e.g. C), which has been
compared to at least one of the other treatments. A
NMA assumes that given the knowledge of the estimate
of interventions A versus B and interventions B versus C,
it is possible to deduce information about the relationship
between interventions A and C. Specifically, NMA model-
ling accepts that estimate of A versus C is equal to the dif-
ference between A versus B and B versus C.
Based on this principle, a NMA random effects model
based on the SMD will be generated in WinBUGS 14.
The model will include all modalities for which there is
available data. The model will be based on a Bayesian
framework, and vague priors will be used to ensure that
results would be as close as possible to findings obtained
from a frequentist approach. This will be implemented
by setting the distributions with a very broad precision.
The NMA will generate pairwise comparisons between
all modalities and rankings of the modalities and will as-
sess the probability that each modality is the best.
There are both benefits and risks to this form of ana-
lysis. With randomised controlled trials becoming more
popular [16] and head-to-head trials being atypical, it is
important to be able to create these comparisons. The
increasing use of this analysis within psychological and,
particularly, eHealth research will impact on the synthe-
sising of research and will allow new inferences to be
drawn. NMA allows for the comparison of interventions
that have not previously been compared and generates
comparisons between all modalities. It allows for the
generation of probability statements (for example, treat-
ment A is the best), which are needed by decision-
makers. However, while the use of NMA is promising, it
has also been considered somewhat controversial [27].
The assumptions that underlie the model, the issues
with inconsistency and the observational nature of indir-
ect comparisons all fuel certain misgivings. However,
when appropriately and conservatively employed as a
tool to foster new research and medical decisions in a
particular direction, they have an extremely beneficial
and influential application.
Assessment of inconsistency
Statistical heterogeneity and inconsistency
Given that this review will classify studies by the modal-
ities used to deliver the interventions, substantial hetero-
geneity is anticipated. Statistical heterogeneity will be
assessed using the I2 statistic, which calculates the per-
centage of variability that is due to heterogeneity rather
than chance, and Τau2, an estimate of the between-study
variance in a random effects meta-analysis. The
Cochrane Handbook suggests that an I2 value of less
than 40% is a non-significant amount of heterogeneity; a
value of between 30 and 60% represents moderate het-
erogeneity, a value of between 50 and 90% suggests sub-
stantial heterogeneity and an I2 value of between 75 and
100% represents considerable heterogeneity. A Τ2 value
of greater than 1 indicates substantial heterogeneity.
Heterogeneity will be assessed by Stata as part of the ex-
ploratory pairwise meta-analysis and WinBUGS as part
of the NMA.
The underlying assumption of a NMA is consistency
of the data used in the analysis. If the network contains
a closed loop, a formal test of consistency will be con-
ducted. If the assumption is upheld, it indicates that the
treatment effect from direct evidence is consistent with
the treatment effect from indirect evidence [28]. If the
network is star-shaped, then inconsistency cannot exist.
Risk of bias across studies
As part of the exploratory analysis, funnel plots of the
main outcomes within each modality will be created
using Stata 13 [25]. These plots will be assessed for sym-
metry to determine if publication bias is present. The
Egger test, a significance test which investigates whether
the study size is related to the study estimate, will also
be conducted using Stata 13 [25]. This will be used to
assess publication bias for continuous outcomes.
Additional analyses
The primary focus of the addition of study-level covari-
ates is to reduce heterogeneity; by allowing the NMA to
take account of additional information, the differences
between the studies in each modality can be minimised.
Each covariate, age, gender, mean years in pain, contact,
diagnosis, intervention etc. will be added individually to
the model. The fitting of the model will be assessed by
investigating the reduction in deviance information cri-
terion (DIC). Covariates that reduce the DIC by at least
5 points will be considered to add strength to the model.
All available covariates will be added individually to the
model, and on each occasion, the covariate that caused
the greatest reduction will be added to the model. This
process will be continued until all suitable covariates are
added. The meta-regression NMA will also return infor-
mation on each of the added covariates (e.g. whether the
investigated modalities are more effective for males or
females, for older or young patients etc.).
Sensitivity analysis: model
The model created using WinBUGS 1.4 requires initial
values to give the simulation a starting point. The influ-
ence of these initial values is lost during the burn-in
phase. In order to ensure that all influence is lost, sensi-
tivity analyses will be run using additional initial values.
They will also be conducted with a different length of
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burn-in (i.e. from 10,000 to 100,000 simulations) to en-
sure that the burn-in was adequate. A further sensitivity
analysis will be run to assess whether the priors used
were truly uninformative. This will be assessed by testing
other priors and determining whether the SMD was af-
fected (e.g. gamma prior). Additionally, the model will
be run to two chains in order to assess whether the
model has converged, and this will be determined by
assessing the history plots produced by WinBUGS; if the
plot shows tight iterations, it implies that there is no evi-
dence of non-convergence. If non-convergence is evi-
dent, the model will be run with an increased number of
samples until non-convergence is no longer evident.
Sensitivity analysis: trial quality
The influence of studies that are at a high risk of bias
will be investigated by removing them from the explora-
tory pairwise meta-analysis one at a time. If they are
considered to have had undue influence over the synthe-
sised effect estimate (i.e. there is a significant change in
the estimate), they will be removed from further analysis.
The influence of lower quality studies will only be taken
into account for the primary outcome.
Discussion
Contribution to literature
There has been an increase in the number and types of
eHealth interventions for chronic pain. To date, there is
no clear indication as to which eHealth modality is the
most effective or to what extent the modality type itself
has an impact on the success of an intervention for
chronic pain. The proposed review will address this gap
in the literature.
The research will extend the review of Heapy et al. on
technology-assisted chronic pain interventions by (a) in-
corporating the Cochrane review search strategy from
Eccleston et al. with the search strategy of Heapy et al.,
(b) not restricting the eHealth modalities included in the
review and (c) quantitatively comparing these different
eHealth modalities to identify the most efficacious. Spe-
cifically, the NMA will return rankings of modalities,
which will determine which modality supports the most
and least effective interventions. Such information will
be an important guide for researchers, as they choose
which modality to deploy in the context of delivering an
intervention via technology for chronic pain. In particu-
lar, the rankings for modalities will provide pragmatic
support for choosing certain modalities over others. For
instance, if one modality is found to be extremely effica-
cious but happens to be the most costly, it might not be
feasible for researchers to use this option; therefore, it
would be important to know which of the cheaper mo-
dalities is the next most effective. Moreover, the narra-
tive analysis will complement the NMA in comparing
each eHealth modality, by exploring in more nuanced
detail the reasons for the NMA results. It will examine
factors, such as methodological issues, therapist contact
level and participant attrition rates, for example, that will
provide important insight into the strengths and weak-
nesses of each eHealth modality, in the context of
chronic pain research.
Limitations
In this study, there is an expectation of considerable het-
erogeneity; the interventions will be grouped by the mo-
dality by which they were delivered rather than the
intervention that they provide. While the study will at-
tempt to limit this through the addition of study-level
covariates, any remaining heterogeneity casts doubt on
the accuracy of estimates. Technically, as long as there is
at least one study based on a particular modality, it can
be included in the network. There will, however, be in-
creased imprecision surrounding the effect estimate, as
demonstrated by widening credible intervals. Some of
the modalities included in this study have had little ex-
ploration which may impact the accuracy of their gener-
ated results.
Implications of the review
To our knowledge, no previous review has conducted a
NMA on eHealth modalities used to deliver interven-
tions for chronic pain. This review will provide a clear
direction for future research in the area of eHealth inter-
ventions for chronic pain.
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Abbreviations
CP: Chronic pain; DIC: Deviance information criterion; HRQoL: Health-related
quality of life; IVR: Interactive voice response; NMA: Network meta-analysis;
PRISMA NMA: The PRISMA extension statement for reporting of systematic
reviews incorporating network meta-analyses of health care interventions;
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-
Analyses; PROSPERO: Prospective Register of Systematic Reviews;
RCT: Randomised control trial; SMD: Standardised mean difference
Acknowledgements
We acknowledge the work of the original authors whose studies we have
used to complete this review.
Funding
This work is supported by the Irish Health Research Board Research Leaders
Award, grant reference (Brian McGuire, RLA/2013).
Slattery et al. Systematic Reviews  (2017) 6:45 Page 7 of 8
Availability of data and materials
The datasets during and/or analysed during the current study are available
from the corresponding author on reasonable request.
Authors’ contributions
BWS, SH, KF and L’OC are involved in the design, delivery and analysis of
the systematic review and network meta-analysis and also drafted the
manuscript. KB, CPD, SO’H and JE were involved in the editing of the
manuscript. BMcG supervised the study and contributed to editing the
manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not Applicable.
Ethics approval and consent to participate
NA.
Received: 10 August 2016 Accepted: 11 January 2017
References
1. Catwell L, Sheikh A. Evaluating eHealth interventions: the need for
continuous systemic evaluation. PLOS Med. 2009; doi:10.1371/journal.pmed.
1000126
2. Showell C, Nøhr C. How should we define eHealth, and does the definition
matter? Studies in Health Technology and Informatics. 2012; doi:10.3233/
978-1-61499-101-4-881
3. Heapy AA, Higgins DM, Cervone D, Wandner L, Fenton BT, Kerns RD. A
systematic review of technology-assisted self-management interventions for
chronic pain: looking across treatment modalities. The Clinical Journal of
Pain. 2015; doi:10.1097/AJP.0000000000000185
4. Liaw ST, Humphreys JS. Rural eHealth paradox: it’s not just geography!
Australian Journal of Rural Health. 2006; doi:10.1111/j.1440-1584.2006.00786.x
5. Stroetmann KA, Jones T, Dobrev A, Stroetmann VN. eHealth is Worth it. The
economic benefits of implemented eHealth solutions at ten European sites.
Luxembourg Office for Official Publications of the European Communities.
European Community. 2006
6. Andersson G, Lundström P, Ström L. Internet-based treatment of headache:
does telephone contact add anything? Headache. 2003;43:353–61. doi:10.
1046/j.1526-4610.2003.03070.x.
7. Botella C, Garcia-Palacios A, Vizcaíno Y, Herrero R, Baños RM, Belmonte MA.
Virtual reality in the treatment of fibromyalgia: a pilot study. Cyberpsychol
Behav Soc Netw. 2013;16:215–23. doi:10.1089/cyber.2012.1572.
8. Heapy A, Sellinger J, Higgins D, Chatkoff D, Bennett TC, Kerns RD. Using
interactive voice response to measure pain and quality of life. Pain
Medicine. 2007; doi:10.1111/j.1526-4637.2007.00378.x
9. Nes AAG, van Dulmen S, Eide E, Finset A, Kristjánsdóttir OB, Steen IS, Eide H.
The development and feasibility of a web-based intervention with diaries
and situational feedback via smartphone to support self-management in
patients with diabetes type 2. Diabetes Research and Clinical Practice. 2012;
doi:10.1016/j.diabres.2012.04.019
10. Reed JL, Prince SA, Cole CA, et al. E-health physical activity interventions
and moderate-to-vigorous intensity physical activity levels among working-
age women: a systematic review protocol. Systematic Reviews. 2015; doi:10.
1186/2046-4053-4-3
11. Cappuro D, Ganzinger M, Perez-Lu J, Knaup P. Effectiveness of eHealth
interventions and information needs in palliative care: a systematic literature
review. J Med Internet Res. 2014; doi: 10.2196/jmir.2812
12. Muellmann S, Forberger S, Mollers T, Zeeb H, Pischke CR. Effectiveness of
eHealth interventions for the promotion of physical activity in older adults:
a systematic review protocol. Systematic Reviews. 2016; doi: 10.1186/
s13643-016-0223-7
13. Merskey H. Pain terms: a list with definitions and notes on usage.
Recommended by the IASP Subcommittee on Taxonomy. Pain. 1979;6(3):249.
14. Raftery MN, Sarma K, Murphy AW, et al. Chronic pain in the Republic of
Ireland—community prevalence, psychosocial profile and predictors of
pain-related disability: results from the Prevalence, Impact and Cost of
Chronic Pain (PRIME) study, part 1. Pain. 2011; doi:10.1016/j.pain.2011.01.019
15. Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management
approaches for people with chronic conditions: a review. Patient Educ
Couns. 2002;48:177–87. doi:10.1016/S0738-3991(02)00032-0.
16. Eccleston C, Fisher E, Craig L, Duggan GB, Rosser BA, Keogh E. Psychological
therapies (Internet‐delivered) for the management of chronic pain in adults.
The Cochrane Library. 2014; doi:10.1002/14651858.CD010152.pub2
17. Newman MG, Szkodny LE, Llera SJ, Przeworski A. A review of technology-
assisted self-help and minimal contact therapies for anxiety and depression:
is human contact necessary for therapeutic efficacy? Clinical Psychology
Review. 2011; doi:10.1016/j.cpr.2010.09.008
18. Richards D, Richardson T. Computer-based psychological treatments for
depression: a systematic review and meta-analysis. Clinical Psychology
Review. 2012; doi:10.1016/j.cpr.2012.02.004
19. Jansen JP, Trikalinos T, Cappelleri JC, Daw J, Andes S, Eldessouki R, Salanti G.
Indirect treatment comparison/network meta-analysis study questionnaire
to assess relevance and credibility to inform health care decision making:
an ISPOR-AMCP-NPC Good Practice Task Force report. Value in Health. 2014;
doi:10.1016/j.jval.2014.01.004
20. Naci H, Ioannidis JPA. Comparative effectiveness of exercise and drug
interventions on mortality outcomes: metaepidemiological study. British
Medical Journal. 2013; doi:10.1136/bmj.f5577
21. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for
systematic reviews and meta-analyses: the PRISMA statement. Annals of
Internal Medicine. 2009; doi:10.7326/0003-4819-151-4-200908180-00135
22. Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for
reporting of systematic reviews incorporating network meta-analyses of
health care interventions: checklist and explanations. Annals of Internal
Medicine. 2015; doi:10.7326/M14-2385
23. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP,
Witter J. Core outcome measures for chronic pain clinical trials: IMMPACT
recommendations. Pain, 2005; doi:10.1016/j.pain.2004.09.012
24. Clarivate Analytics (previously Thomson Reuters). Endnote X7 Referencing
Software. New York, NY. 2016.
25. StataCorp LP. Stata. College Station, TX. 2013.
26. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS—a Bayesian
modelling framework: concepts, structure, and extensibility. Statistics and
Computing. 2000; doi:10.1023/A:1008929526011
27. Salanti G. Indirect and mixed‐treatment comparison, network, or multiple‐
treatments meta‐analysis: many names, many benefits, many concerns for
the next generation evidence synthesis tool. Research Synthesis Methods.
2012; doi:10.1002/jrsm.1037
28. Donegan S, Williamson P, D’Alessandro U, Tudur Smith C. Assessing key
assumptions of network meta‐analysis: a review of methods. Research
Synthesis Methods. 2013; doi:10.1002/jrsm.1085
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Slattery et al. Systematic Reviews  (2017) 6:45 Page 8 of 8
